Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
BMJ Case Reports|April 25, 2025
Primary pleural Müllerian origin tumour: a clinical perspectiveAbhinav Dewan, Mansi Sharma, Ritwika Choudhury, et al.
Journal of Carcinogenesis|September 17, 2014
Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinomaDinesh Chandra Doval, Saud Azam, Rupal Sinha, et al.
The Indian Journal of Radiology & Imaging|September 24, 2021
Hyperprogression after Immunotherapy: Nivolumab. Analysis of Imaging Findings Associated with Hyperprogression and Tumor Growth KineticsRishu Singla, Ayushi Gupta, Ullas Batra, et al.
Clinical and Experimental Medicine|March 12, 2021
Malfeasance of KRAS mutations in carcinogenesisRupal Tripathi, Shrinidhi Nathany, Anurag Mehta, et al.
International Journal of Clinical Oncology|April 12, 2021
Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched studyUllas Batra, Mansi Sharma, Shrinidhi Nathany, et al.
Journal of Cancer Research and Therapeutics|February 20, 2024
A novel EML4-NTRK3 fusion in lung adenocarcinoma with dramatic response to entrectinibUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.
Oncology Research and Treatment|March 22, 2017
MET Amplification and Response to MET Inhibitors in Stage IV Lung AdenocarcinomaMoushumi Suryavanshi, Aekta Shah, Dushyant Kumar, et al.
American Journal of Translational Research|May 13, 2022
Machine learning-based algorithm demonstrates differences in del19 and L858R EGFR subgroups in non-small cell lung cancer: a single center experienceUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2025
Prognosis of TP53 and Its Concomitant EGFR Mutation in Lung Cancer Especially Non-Small Cell Lung CancerAnurag Mehta, Arpita Ghosh Mitra, Samson Mani, et al.
World Journal of Nuclear Medicine|May 30, 2017
Can <sup>18</sup>F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography?Manoj Gupta, Anupama Datta, Partha S Choudhury, et al.
Pageof 11